Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christine Klaskin

The proxy statement of Agenus Inc reports total compensation of $332,019 for Christine Klaskin in fiscal 2025, including a base salary of $298,224. Disclosed compensation is on record for 6 fiscal years. Christine Klaskin has spoken on 4 earnings calls across 2 companies, most recently for Agenus Inc on May 12, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Agenus Inc

Other people whose current roles at this company are on record from its filings.

Leadership on record at MiNK Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Agenus Inc (AGEN) $298,224 $332,019
2025 MiNK Therapeutics, Inc. (INKT) $29,822 $29,822
2024 Agenus Inc (AGEN) $298,224 $483,477
2024 MiNK Therapeutics, Inc. (INKT) $29,822 $29,822
2023 Agenus Inc (AGEN) $296,239 $712,747
2023 MiNK Therapeutics, Inc. (INKT) $29,624 $29,624
2022 Agenus Inc (AGEN) $287,178 $628,125
2022 MiNK Therapeutics, Inc. (INKT) $27,244 $27,244
2021 Agenus Inc (AGEN) $275,725 $574,832
2021 MiNK Therapeutics, Inc. (INKT) $20,019 $20,019
2020 Agenus Inc (AGEN) $285,166 $507,705

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.